Bradley Ekstrand is an expert in the field of Oncology. He went to Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Bradley C. Ekstrand, MD is a published doctor as well. He has 5 publications published. The latest was: Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. He accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1528125135 | |
NPPES Provider LastName | EKSTRAND | |
NPPES Provider FirstName | BRADLEY | |
NPPES Provider ZIPCode | 944023913 | |
NPPES Provider State | CA | |
Specialty Description | Medical Oncology | |
Total Claim Count | 592.0 | |
Distinct Opioid Count | 1.0 | |
Opioid Claim Count | 34.0 | |
Percent Opioid Claims | 5.74 |
National Provider Identifier [NPI] | 1528125135 |
Last Name Of The Provider | EKSTRAND |
First Name Of The Provider | BRADLEY |
View All |
Dr. Kent Adler, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Teja Bedi, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. John V. Siebel, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Mika Kakefuda, MD
This Doctor is OpenDoctor Recommended. |